DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc.

DMAC
DiaMedica Therapeutics Inc.US flagNASDAQ Capital Market
5.65
USD
-0.12
- -
304.44MMarket Cap

DiaMedica Therapeutics Inc. (DMAC) Stock Splits

Learn about DiaMedica Therapeutics Inc.'s most recent 1-for-20 basis stock split on November 15, 2018. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about DiaMedica Therapeutics Inc.'s most recent stock split

Split Date: 2018-11-15
Split Ratio: 1:20
Price Before Split: $0.26
Price After Split: $0.01

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 20.00 times fewer shares (a 1:20 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of DiaMedica Therapeutics Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2018-11-151:20Yes$0.26$0.01

About DiaMedica Therapeutics Inc.

Company overview and industry information

DiaMedica Therapeutics Inc. (DMAC) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to DiaMedica Therapeutics Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.